| Title |
Single- and cross-commodity discounting among cocaine addicts: the commodity and its temporal location determine discounting rate
|
|---|---|
| Published in |
Psychopharmacology, April 2011
|
| DOI | 10.1007/s00213-011-2272-x |
| Pubmed ID | |
| Authors |
Warren K. Bickel, Reid D. Landes, Darren R. Christensen, Lisa Jackson, Bryan A. Jones, Zeb Kurth-Nelson, A. David Redish |
| Abstract |
Intertemporal choice has provided important insights into understanding addiction, predicted drug-dependence status, and outcomes of treatment interventions. However, such analyses have largely been based on the choice of a single commodity available either immediately or later (e.g., money now vs. money later). In real life, important choices for those with addiction depend on making decisions across commodities, such as between drug and non-drug reinforcers. To date, no published study has systematically evaluated intertemporal choice using all combinations of a drug and a non-drug commodity. |
Mendeley readers
The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| France | 1 | <1% |
| Romania | 1 | <1% |
| Unknown | 114 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 26 | 22% |
| Researcher | 18 | 15% |
| Student > Doctoral Student | 11 | 9% |
| Student > Bachelor | 10 | 9% |
| Professor | 8 | 7% |
| Other | 24 | 21% |
| Unknown | 20 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 48 | 41% |
| Neuroscience | 11 | 9% |
| Social Sciences | 8 | 7% |
| Medicine and Dentistry | 7 | 6% |
| Economics, Econometrics and Finance | 5 | 4% |
| Other | 9 | 8% |
| Unknown | 29 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 August 2011.
All research outputs
#5,454,593
of 22,649,029 outputs
Outputs from Psychopharmacology
#1,605
of 5,328 outputs
Outputs of similar age
#30,322
of 108,820 outputs
Outputs of similar age from Psychopharmacology
#8
of 31 outputs
Altmetric has tracked 22,649,029 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,328 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,820 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.